The burden of liver disease in human immunodeficiency virus-infected patients

Massimo Puoti1, Maria Cristina Moioli, Giovanna Travi

  • 1Department of Infectious Diseases, AO Ospedale Niguarda Ca' Granda, Milano, Italy. massimopuoti@libero.it

Insights

Effective HIV treatment has increased liver disease in patients. Viral hepatitis coinfections, drug toxicity, and alcohol contribute to liver damage, necessitating vaccinations like anti-HAV for those with HIV.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Combined antiretroviral therapy transformed human immunodeficiency virus (HIV) into a chronic condition.
  • Liver disease is a leading cause of death in HIV-infected individuals, often due to cirrhosis and hepatocellular carcinoma from hepatitis B and C coinfections.
  • Antiretroviral drug toxicity, nonalcoholic fatty liver disease, alcohol consumption, and viral hepatitis E and A infections also contribute to liver injury in this population.

Purpose of the Study:

  • To review the spectrum of liver diseases affecting individuals living with HIV.
  • To highlight the increasing incidence of noncirrhotic portal hypertension.
  • To emphasize the importance of vaccination against hepatitis A virus (HAV) in at-risk HIV-positive individuals.

Main Methods:

  • Literature review and synthesis of existing research on liver disease in HIV-infected populations.
  • Analysis of etiological factors contributing to liver morbidity and mortality.
  • Evaluation of current recommendations for liver disease management and prevention in HIV.

Main Results:

  • Hepatitis C virus and hepatitis B virus coinfections are primary drivers of mortality through cirrhosis and hepatocellular carcinoma.
  • Alcohol consumption plays a significant role in liver injury.
  • Noncirrhotic portal hypertension is an emerging concern, and acute/chronic hepatitis E and A infections are reported causes of liver damage.

Conclusions:

  • HIV management has shifted focus towards managing chronic comorbidities, including liver disease.
  • Comprehensive strategies addressing viral coinfections, drug toxicity, alcohol use, and vaccinations are crucial for improving outcomes in HIV patients.
  • Anti-HAV vaccination is recommended for at-risk individuals living with HIV to prevent HAV-related liver damage.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...